AU5838601A - 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity - Google Patents

16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity

Info

Publication number
AU5838601A
AU5838601A AU5838601A AU5838601A AU5838601A AU 5838601 A AU5838601 A AU 5838601A AU 5838601 A AU5838601 A AU 5838601A AU 5838601 A AU5838601 A AU 5838601A AU 5838601 A AU5838601 A AU 5838601A
Authority
AU
Australia
Prior art keywords
estrogenic activity
steroid compounds
selective estrogenic
carbocyclic condensed
carbocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU5838601A
Other languages
English (en)
Inventor
Hubert Jan Jozef Loozen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of AU5838601A publication Critical patent/AU5838601A/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU5838601A 2000-06-06 2001-05-01 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity Pending AU5838601A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201986 2000-06-06
PCT/EP2001/004868 WO2002000682A1 (en) 2000-06-06 2001-05-01 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity

Publications (1)

Publication Number Publication Date
AU5838601A true AU5838601A (en) 2002-01-08

Family

ID=8171601

Family Applications (2)

Application Number Title Priority Date Filing Date
AU5838601A Pending AU5838601A (en) 2000-06-06 2001-05-01 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity
AU2001258386A Ceased AU2001258386B2 (en) 2000-06-06 2001-05-01 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001258386A Ceased AU2001258386B2 (en) 2000-06-06 2001-05-01 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity

Country Status (26)

Country Link
US (3) US7868193B2 (enExample)
EP (1) EP1294739B1 (enExample)
JP (1) JP5095902B2 (enExample)
KR (1) KR100769865B1 (enExample)
CN (1) CN1235908C (enExample)
AR (1) AR028080A1 (enExample)
AT (1) ATE293124T1 (enExample)
AU (2) AU5838601A (enExample)
BR (1) BR0111445A (enExample)
CA (1) CA2410220C (enExample)
CZ (1) CZ20024014A3 (enExample)
DE (1) DE60110069T2 (enExample)
DK (1) DK1294739T3 (enExample)
ES (1) ES2240454T3 (enExample)
HU (1) HUP0301190A3 (enExample)
IL (1) IL152957A0 (enExample)
MX (1) MXPA02012117A (enExample)
NO (1) NO324247B1 (enExample)
PE (1) PE20020214A1 (enExample)
PL (1) PL203732B1 (enExample)
PT (1) PT1294739E (enExample)
RU (1) RU2255090C2 (enExample)
SK (1) SK286852B6 (enExample)
TW (1) TWI225068B (enExample)
WO (1) WO2002000682A1 (enExample)
ZA (1) ZA200209452B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8367648B2 (en) 2009-06-10 2013-02-05 Msd Oss B.V. Substituted 16,17-annellated steroid compounds for use in womens healthcare
TW201109346A (en) * 2009-06-10 2011-03-16 Organon Nv Substituted 16,17-annellated steroid compounds for use in women's healthcare

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194821A (en) * 1963-12-30 1965-07-13 Abbott Lab 17alpha-substituted 17beta-hydroxyestrenes
CA2200423C (en) 1996-03-26 2006-12-19 Sietse Mosselman Novel estrogen receptor
IL123195A (en) * 1997-02-21 2002-11-10 Akzo Nobel Nv Steroid compounds with anti-pregnancy activity and against bone thinning, preparation and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
CZ20024014A3 (cs) 2003-04-16
US20100249083A1 (en) 2010-09-30
PE20020214A1 (es) 2002-03-13
JP2004501931A (ja) 2004-01-22
SK17072002A3 (sk) 2003-06-03
SK286852B6 (sk) 2009-06-05
IL152957A0 (en) 2003-06-24
PL359238A1 (en) 2004-08-23
CA2410220A1 (en) 2002-01-03
US20040102426A1 (en) 2004-05-27
DE60110069T2 (de) 2005-09-22
CA2410220C (en) 2009-04-28
KR100769865B1 (ko) 2007-10-25
EP1294739A1 (en) 2003-03-26
ATE293124T1 (de) 2005-04-15
DE60110069D1 (de) 2005-05-19
ES2240454T3 (es) 2005-10-16
BR0111445A (pt) 2003-06-03
ZA200209452B (en) 2004-02-20
NO324247B1 (no) 2007-09-17
US20110224183A1 (en) 2011-09-15
CN1235908C (zh) 2006-01-11
JP5095902B2 (ja) 2012-12-12
DK1294739T3 (da) 2005-08-01
NO20025793D0 (no) 2002-12-02
NO20025793L (no) 2002-12-02
MXPA02012117A (es) 2003-06-06
US7868193B2 (en) 2011-01-11
HK1052012A1 (en) 2003-08-29
WO2002000682A1 (en) 2002-01-03
PT1294739E (pt) 2005-06-30
RU2255090C2 (ru) 2005-06-27
KR20030028752A (ko) 2003-04-10
PL203732B1 (pl) 2009-11-30
CN1433426A (zh) 2003-07-30
EP1294739B1 (en) 2005-04-13
HUP0301190A3 (en) 2010-03-29
AU2001258386B2 (en) 2005-08-18
AR028080A1 (es) 2003-04-23
HUP0301190A2 (hu) 2003-08-28
TWI225068B (en) 2004-12-11

Similar Documents

Publication Publication Date Title
MXPA02012897A (es) Combinaciones de bisfosfonatos, agentes estrigenicos y opcionalmente estrogenos.
CY2325B1 (en) Estrogenic agents.
MXPA01011070A (es) Derivados de esteroides.
ZA200003927B (en) 1,2,4,5-tetrahydro-benzo[d]jazepines.
PL362982A1 (en) Benzothiophene derivative compounds, process for the preparation and use thereof
ZA993345B (en) Nefazodone dosage form.
MXPA02012896A (es) Combinaciones de estatinas, agentes estrogenicos y opcionalmente estrogenos.
MXPA02010259A (es) Formulacion de accion rapida de un inhibidor selectivo de ciclooxigenasa-2.
ZA200108968B (en) New compounds.
EG23909A (en) Vatamin d, analogs
PL350360A1 (en) 16−hydroxyestratrienes as selective estrogens
AU2001293512A8 (en) Aldehyde-releasing compounds
ZA200006173B (en) Crystalline Efavirenz.
IL149424A0 (en) 14,15-beta-methylene substituted androgens
GB0316320D0 (en) Remedies for dermatophytosis
AU5838601A (en) 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity
AU3964400A (en) Selective estrogenic compounds
SI1272504T1 (sl) 8beta-hidrokarbilno substituirani estratrieni kotestrogeni s selektivnim učinkom
PH12001001922B1 (en) Crystalline therapeutic agent.
ZA991761B (en) New agent.
ZA200300417B (en) 16alpha-methyl or ethyl substituted estrogens.
MXPA03004658A (es) Compuestos activos en el receptor glucocorticoide ii.
DK0973790T3 (da) Estra-5(10),7-diener med østrogen aktivitet
GB0023662D0 (en) Supported catalyst
CA85870S (en) Deodorizing bar